November 11, 2005Metabolic Disorder Collaboration Agreement • March 14th, 2006 • Curagen Corp • Services-commercial physical & biological research
Contract Type FiledMarch 14th, 2006 Company IndustryReference is made to the Metabolic Disorder Collaboration Agreement dated January 12, 2001 between Bayer Corporation and CuraGen Corporation (as previously amended, the “Agreement”). Terms which are defined in the Agreement are used herein as so defined. This letter will set forth our agreement with respect to an amendment of the Agreement.
May 30, 2006 CuraGen Corporation Branford, CT 06405 Attention: Executive Vice President, Business DevelopmentMetabolic Disorder Collaboration Agreement • August 9th, 2006 • Curagen Corp • Services-commercial physical & biological research
Contract Type FiledAugust 9th, 2006 Company IndustryReference is made to the Metabolic Disorder Collaboration Agreement dated January 12, 2001 between Bayer Corporation and CuraGen Corporation (as previously amended, the “Agreement”). Terms which are defined in the Agreement are used herein as so defined. This letter will set forth our agreement with respect to the closing of the Qualified Target Production Phase of the Agreement and addresses issues not previously contemplated in the Agreement with respect to such closing.
andMetabolic Disorder Collaboration Agreement • March 28th, 2001 • Curagen Corp • Services-commercial physical & biological research • Delaware
Contract Type FiledMarch 28th, 2001 Company Industry Jurisdiction